IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹969 Cr | ₹1,014 Cr | ₹902 Cr | ₹614 Cr | ₹190 Cr |
What is the latest Total Non-Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹969 Cr |
| Mar2024 | ₹1,014 Cr |
| Mar2023 | ₹902 Cr |
| Mar2022 | ₹614 Cr |
| Mar2021 | ₹190 Cr |
How is Total Non-Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹969 Cr | -4.46 | |
| Mar2024 | ₹1,014 Cr | 12.50 | |
| Mar2023 | ₹902 Cr | 46.89 | |
| Mar2022 | ₹614 Cr | 223.62 | |
| Mar2021 | ₹190 Cr | - | |
Compare Total Non-Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹37,698.6 Cr | -1.7% | -0.8% | 10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -1.7% |
-0.8% |
10.6% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses